{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:22:50Z","timestamp":1793038970775,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7922","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2022,8,11]]},"DOI":"10.1038\/s41586-022-04993-7","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T16:31:33Z","timestamp":1658939493000},"page":"368-373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Dual action of ketamine confines addiction liability"],"prefix":"10.1038","volume":"608","author":[{"given":"Linda D.","family":"Simmler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotfi C.","family":"Hadjas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Hiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud","family":"van Zessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7917-4596","authenticated-orcid":false,"given":"Christian","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"4993_CR1","doi-asserted-by":"crossref","unstructured":"Bellone, C., Loureiro, M. & Luscher, C. Drug-evoked synaptic plasticity of excitatory transmission in the ventral tegmental area. Cold Spring Harb. Perspect. Med. 11, a039701 (2021).","DOI":"10.1101\/cshperspect.a039701"},{"key":"4993_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neuropharm.2004.06.032","volume":"47","author":"G Di Chiara","year":"2004","unstructured":"Di Chiara, G. et al. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47, 227\u2013241 (2004).","journal-title":"Neuropharmacology"},{"key":"4993_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41583-020-0289-z","volume":"21","author":"C L\u00fcscher","year":"2020","unstructured":"L\u00fcscher, C., Robbins, T. W. & Everitt, B. J. The transition to compulsion in addiction. Nat. Rev. Neurosci. 21, 247\u2013263 (2020).","journal-title":"Nat. Rev. Neurosci."},{"key":"4993_CR4","doi-asserted-by":"publisher","first-page":"e437","DOI":"10.1371\/journal.pmed.0030437","volume":"3","author":"C L\u00fcscher","year":"2006","unstructured":"L\u00fcscher, C. & Ungless, M. A. The mechanistic classification of addictive drugs. PLoS Med. 3, e437 (2006).","journal-title":"PLoS Med."},{"key":"4993_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/367607a0","volume":"367","author":"NP Franks","year":"1994","unstructured":"Franks, N. P. & Lieb, W. R. Molecular and cellular mechanisms of general anaesthesia. Nature 367, 607\u2013614 (1994).","journal-title":"Nature"},{"key":"4993_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.117.015198","volume":"70","author":"P Zanos","year":"2018","unstructured":"Zanos, P. et al. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol. Rev. 70, 621\u2013660 (2018).","journal-title":"Pharmacol. Rev."},{"key":"4993_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1213\/00000539-200301000-00030","volume":"96","author":"M Masuzawa","year":"2003","unstructured":"Masuzawa, M. et al. Pentobarbital inhibits ketamine-induced dopamine release in the rat nucleus accumbens: a microdialysis study. Anesth. Analg. 96, 148\u2013152 (2003).","journal-title":"Anesth. Analg."},{"key":"4993_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1124\/jpet.116.233627","volume":"358","author":"JM Witkin","year":"2016","unstructured":"Witkin, J. M. et al. The rapidly acting antidepressant ketamine and the mGlu2\/3 receptor antagonist LY341495 rapidly engage dopaminergic mood circuits. J. Pharmacol. Exp. Ther. 358, 71\u201382 (2016).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"4993_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00213-006-0344-0","volume":"186","author":"CL Littlewood","year":"2006","unstructured":"Littlewood, C. L. et al. Mapping the central effects of ketamine in the rat using pharmacological MRI. Psychopharmacology 186, 64\u201381 (2006).","journal-title":"Psychopharmacology"},{"key":"4993_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/00008877-199603000-00007","volume":"7","author":"BA Rocha","year":"1996","unstructured":"Rocha, B. A., Ward, A. S., Egilmez, Y., Lytle, D. A. & Emmett-Oglesby, M. W. Tolerance to the discriminative stimulus and reinforcing effects of ketamine. Behav. Pharmacol. 7, 160\u2013168 (1996).","journal-title":"Behav. Pharmacol."},{"key":"4993_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00213-010-2062-x","volume":"214","author":"MT De Luca","year":"2011","unstructured":"De Luca, M. T. & Badiani, A. Ketamine self-administration in the rat: evidence for a critical role of setting. Psychopharmacology 214, 549\u2013556 (2011).","journal-title":"Psychopharmacology"},{"key":"4993_CR12","doi-asserted-by":"crossref","unstructured":"Zanos, P. et al. A negative allosteric modulator for alpha5 subunit-containing GABA receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA receptor antagonist ketamine in mice. eNeuro 4, ENEURO.0285-16.2017 (2017).","DOI":"10.1523\/ENEURO.0285-16.2017"},{"key":"4993_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0024-3205(00)00639-1","volume":"67","author":"T Suzuki","year":"2000","unstructured":"Suzuki, T. et al. Effects of the non-competitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice. Life Sci. 67, 383\u2013389 (2000).","journal-title":"Life Sci."},{"key":"4993_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.neuron.2011.01.017","volume":"69","author":"C Luscher","year":"2011","unstructured":"Luscher, C. & Malenka, R. C. Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69, 650\u2013663 (2011).","journal-title":"Neuron"},{"key":"4993_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-neuro-070815-013920","volume":"39","author":"C Luscher","year":"2016","unstructured":"Luscher, C. The emergence of a circuit model for addiction. Annu. Rev. Neurosci. 39, 257\u2013276 (2016).","journal-title":"Annu. Rev. Neurosci."},{"key":"4993_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/35079077","volume":"411","author":"MA Ungless","year":"2001","unstructured":"Ungless, M. A., Whistler, J. L., Malenka, R. C. & Bonci, A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411, 583\u2013587 (2001).","journal-title":"Nature"},{"key":"4993_CR17","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nn1682","volume":"9","author":"C Bellone","year":"2006","unstructured":"Bellone, C. & Luscher, C. Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. Nat. Neurosci. 9, 636\u2013641 (2006).","journal-title":"Nat. Neurosci."},{"key":"4993_CR18","doi-asserted-by":"publisher","first-page":"e15870","DOI":"10.1371\/journal.pone.0015870","volume":"5","author":"MT Brown","year":"2010","unstructured":"Brown, M. T. et al. Drug-driven AMPA receptor redistribution mimicked by selective dopamine neuron stimulation. PLoS One 5, e15870 (2010).","journal-title":"PLoS One"},{"key":"4993_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature06995","volume":"454","author":"KL Conrad","year":"2008","unstructured":"Conrad, K. L. et al. Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature 454, 118\u2013121 (2008).","journal-title":"Nature"},{"key":"4993_CR20","doi-asserted-by":"publisher","first-page":"7921","DOI":"10.1523\/JNEUROSCI.1859-07.2007","volume":"27","author":"S Kourrich","year":"2007","unstructured":"Kourrich, S., Rothwell, P. E., Klug, J. R. & Thomas, M. J. Cocaine experience controls bidirectional synaptic plasticity in the nucleus accumbens. J. Neurosci. 27, 7921\u20137928 (2007).","journal-title":"J. Neurosci."},{"key":"4993_CR21","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/nn.2367","volume":"12","author":"M Mameli","year":"2009","unstructured":"Mameli, M. et al. Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc. Nat. Neurosci. 12, 1036\u20131041 (2009).","journal-title":"Nat. Neurosci."},{"key":"4993_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-018-0789-4","volume":"564","author":"V Pascoli","year":"2018","unstructured":"Pascoli, V. et al. Stochastic synaptic plasticity underlying compulsion in a model of addiction. Nature 564, 366\u2013371 (2018).","journal-title":"Nature"},{"key":"4993_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/BF00175709","volume":"342","author":"MS Brodie","year":"1990","unstructured":"Brodie, M. S. & Dunwiddie, T. V. Cocaine effects in the ventral tegmental area: evidence for an indirect dopaminergic mechanism of action. Naunyn Schmiedebergs Arch. Pharmacol. 342, 660\u2013665 (1990).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"4993_CR24","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1016\/j.celrep.2020.02.092","volume":"30","author":"AC Hunker","year":"2020","unstructured":"Hunker, A. C. et al. Conditional single vector CRISPR\/SaCas9 viruses for efficient mutagenesis in the adult mouse nervous system. Cell Rep. 30, 4303\u20134316 (2020).","journal-title":"Cell Rep."},{"key":"4993_CR25","doi-asserted-by":"crossref","unstructured":"Corre, J. et al. Dopamine neurons projecting to medial shell of the nucleus accumbens drive heroin reinforcement. eLife 7, e39945 (2018).","DOI":"10.7554\/eLife.39945"},{"key":"4993_CR26","doi-asserted-by":"publisher","first-page":"a005710","DOI":"10.1101\/cshperspect.a005710","volume":"4","author":"C Luscher","year":"2012","unstructured":"Luscher, C. & Malenka, R. C. NMDA receptor-dependent long-term potentiation and long-term depression (LTP\/LTD). Cold Spring Harb. Perspect. Biol. 4, a005710 (2012).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"4993_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos, P. et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533, 481\u2013486 (2016).","journal-title":"Nature"},{"key":"4993_CR28","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1124\/dmd.117.078360","volume":"46","author":"S Ganguly","year":"2018","unstructured":"Ganguly, S., Panetta, J. C., Roberts, J. K. & Schuetz, E. G. Ketamine pharmacokinetics and pharmacodynamics are altered by P-glycoprotein and breast cancer resistance protein efflux transporters in mice. Drug Metab. Dispos. 46, 1014\u20131022 (2018).","journal-title":"Drug Metab. Dispos."},{"key":"4993_CR29","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1124\/jpet.118.251652","volume":"367","author":"SK Saland","year":"2018","unstructured":"Saland, S. K. & Kabbaj, M. Sex differences in the pharmacokinetics of low-dose ketamine in plasma and brain of male and female rats. J. Pharmacol. Exp. Ther. 367, 393\u2013404 (2018).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"4993_CR30","doi-asserted-by":"publisher","first-page":"8701","DOI":"10.1523\/JNEUROSCI.20-23-08701.2000","volume":"20","author":"E Valjent","year":"2000","unstructured":"Valjent, E. et al. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 8701\u20138709 (2000).","journal-title":"J. Neurosci."},{"key":"4993_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1073\/pnas.0408305102","volume":"102","author":"E Valjent","year":"2005","unstructured":"Valjent, E. et al. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl Acad. Sci. USA 102, 491\u2013496 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4993_CR32","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1523\/JNEUROSCI.1039-08.2008","volume":"28","author":"J Bertran-Gonzalez","year":"2008","unstructured":"Bertran-Gonzalez, J. et al. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J. Neurosci. 28, 5671\u20135685 (2008).","journal-title":"J. Neurosci."},{"key":"4993_CR33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nature13257","volume":"509","author":"V Pascoli","year":"2014","unstructured":"Pascoli, V. et al. Contrasting forms of cocaine-evoked plasticity control components of relapse. Nature 509, 459\u2013464 (2014).","journal-title":"Nature"},{"key":"4993_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nature10709","volume":"481","author":"V Pascoli","year":"2012","unstructured":"Pascoli, V., Turiault, M. & Luscher, C. Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour. Nature 481, 71\u201375 (2012).","journal-title":"Nature"},{"key":"4993_CR35","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.1099020","volume":"305","author":"V Deroche-Gamonet","year":"2004","unstructured":"Deroche-Gamonet, V., Belin, D. & Piazza, P. V. Evidence for addiction-like behavior in the rat. Science 305, 1014\u20131017 (2004).","journal-title":"Science"},{"key":"4993_CR36","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature08758","volume":"463","author":"KR Tan","year":"2010","unstructured":"Tan, K. R. et al. Neural bases for addictive properties of benzodiazepines. Nature 463, 769\u2013774 (2010).","journal-title":"Nature"},{"key":"4993_CR37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nn1181","volume":"7","author":"HG Cruz","year":"2004","unstructured":"Cruz, H. G. et al. Bi-directional effects of GABAB receptor agonists on the mesolimbic dopamine system. Nat. Neurosci. 7, 153\u2013159 (2004).","journal-title":"Nat. Neurosci."},{"key":"4993_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1523\/JNEUROSCI.4503-03.2004","volume":"24","author":"M Melis","year":"2004","unstructured":"Melis, M. et al. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J. Neurosci. 24, 53\u201362 (2004).","journal-title":"J. Neurosci."},{"key":"4993_CR39","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","volume":"14","author":"P Paoletti","year":"2013","unstructured":"Paoletti, P., Bellone, C. & Zhou, Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat. Rev. Neurosci. 14, 383\u2013400 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"4993_CR40","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","volume":"17","author":"B Moghaddam","year":"1997","unstructured":"Moghaddam, B., Adams, B., Verma, A. & Daly, D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17, 2921\u20132927 (1997).","journal-title":"J. Neurosci."},{"key":"4993_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13809-8","volume":"11","author":"F Ali","year":"2020","unstructured":"Ali, F. et al. Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines. Nat. Commun. 11, 72 (2020).","journal-title":"Nat. Commun."},{"key":"4993_CR42","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/sj.mp.4001093","volume":"7","author":"S Kapur","year":"2002","unstructured":"Kapur, S. & Seeman, P. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors\u2014implications for models of schizophrenia. Mol. Psychiatry 7, 837\u2013844 (2002).","journal-title":"Mol. Psychiatry"},{"key":"4993_CR43","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrn2834","volume":"11","author":"C Luscher","year":"2010","unstructured":"Luscher, C. & Slesinger, P. A. Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease. Nat. Rev. Neurosci. 11, 301\u2013315 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"4993_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1124\/jpet.116.235838","volume":"359","author":"A Can","year":"2016","unstructured":"Can, A. et al. Effects of ketamine and ketamine metabolites on evoked striatal dopamine release, dopamine receptors, and monoamine transporters. J. Pharmacol. Exp. Ther. 359, 159\u2013170 (2016).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"4993_CR45","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.neuron.2008.07.010","volume":"59","author":"D Engblom","year":"2008","unstructured":"Engblom, D. et al. Glutamate receptors on dopamine neurons control the persistence of cocaine seeking. Neuron 59, 497\u2013508 (2008).","journal-title":"Neuron"},{"key":"4993_CR46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1254\/jjp.61.149","volume":"61","author":"Y Uchihashi","year":"1993","unstructured":"Uchihashi, Y., Kuribara, H., Morita, T. & Fujita, T. The repeated administration of ketamine induces an enhancement of its stimulant action in mice. Jpn. J. Pharmacol. 61, 149\u2013151 (1993).","journal-title":"Jpn. J. Pharmacol"},{"key":"4993_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1369-1600.2007.00077.x","volume":"13","author":"JL Wiley","year":"2008","unstructured":"Wiley, J. L., Evans, R. L., Grainger, D. B. & Nicholson, K. L. Age-dependent differences in sensitivity and sensitization to cannabinoids and 'club drugs' in male adolescent and adult rats. Addict. Biol. 13, 277\u2013286 (2008).","journal-title":"Addict. Biol."},{"key":"4993_CR48","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman, R. M. et al. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351\u2013354 (2000).","journal-title":"Biol. Psychiatry"},{"key":"4993_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05382-3","volume":"9","author":"S Bariselli","year":"2018","unstructured":"Bariselli, S. et al. Role of VTA dopamine neurons and neuroligin 3 in sociability traits related to nonfamiliar conspecific interaction. Nat. Commun. 9, 3173 (2018).","journal-title":"Nat. Commun."},{"key":"4993_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.neuron.2008.05.028","volume":"59","author":"LS Zweifel","year":"2008","unstructured":"Zweifel, L. S., Argilli, E., Bonci, A. & Palmiter, R. D. Role of NMDA receptors in dopamine neurons for plasticity and addictive behaviors. Neuron 59, 486\u2013496 (2008).","journal-title":"Neuron"},{"key":"4993_CR51","doi-asserted-by":"publisher","unstructured":"Simmler, L. D. et al. Dual-action of ketamine confines addiction liability. Zenodo https:\/\/doi.org\/10.5281\/zenodo.5772449 (2022).","DOI":"10.5281\/zenodo.5772449"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04993-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04993-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04993-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T14:09:41Z","timestamp":1666534181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04993-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":51,"journal-issue":{"issue":"7922","published-print":{"date-parts":[[2022,8,11]]}},"alternative-id":["4993"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-04993-7","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}